GL Sciences Inc
TSE:7705
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
GL Sciences Inc
TSE:7705
|
JP |
Balance Sheet
Balance Sheet Decomposition
GL Sciences Inc
GL Sciences Inc
Balance Sheet
GL Sciences Inc
| Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
4 772
|
4 506
|
5 077
|
4 970
|
5 415
|
5 891
|
6 358
|
6 119
|
6 557
|
7 451
|
|
| Cash Equivalents |
4 772
|
4 506
|
5 077
|
4 970
|
5 415
|
5 891
|
6 358
|
6 119
|
6 557
|
7 451
|
|
| Total Receivables |
6 507
|
6 140
|
7 143
|
7 927
|
8 419
|
8 402
|
9 198
|
10 344
|
11 671
|
12 747
|
|
| Accounts Receivables |
6 507
|
6 140
|
7 143
|
7 927
|
8 419
|
8 402
|
9 198
|
9 564
|
11 102
|
12 251
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
780
|
568
|
496
|
|
| Inventory |
3 426
|
3 665
|
3 740
|
4 701
|
5 558
|
5 961
|
7 058
|
7 976
|
11 177
|
12 449
|
|
| Other Current Assets |
500
|
416
|
512
|
241
|
302
|
145
|
359
|
390
|
634
|
704
|
|
| Total Current Assets |
15 205
|
14 728
|
16 472
|
17 839
|
19 694
|
20 399
|
22 973
|
24 829
|
30 039
|
33 351
|
|
| PP&E Net |
7 684
|
7 658
|
7 732
|
8 871
|
10 237
|
10 533
|
12 705
|
14 640
|
17 027
|
17 066
|
|
| PP&E Gross |
7 684
|
7 658
|
7 732
|
8 871
|
10 237
|
10 533
|
12 705
|
14 640
|
17 027
|
17 066
|
|
| Accumulated Depreciation |
10 001
|
10 355
|
10 551
|
10 932
|
11 139
|
11 690
|
12 401
|
13 404
|
14 915
|
16 266
|
|
| Intangible Assets |
91
|
123
|
131
|
414
|
369
|
352
|
484
|
466
|
496
|
638
|
|
| Long-Term Investments |
1 535
|
1 098
|
1 257
|
1 768
|
1 233
|
1 042
|
1 561
|
1 986
|
2 514
|
3 383
|
|
| Other Long-Term Assets |
621
|
810
|
844
|
591
|
548
|
765
|
961
|
1 054
|
936
|
1 131
|
|
| Total Assets |
25 135
N/A
|
24 417
-3%
|
26 435
+8%
|
29 482
+12%
|
32 080
+9%
|
33 091
+3%
|
38 683
+17%
|
42 975
+11%
|
51 012
+19%
|
55 568
+9%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
2 592
|
2 186
|
2 648
|
2 963
|
3 423
|
3 026
|
3 324
|
3 908
|
4 078
|
3 977
|
|
| Accrued Liabilities |
385
|
396
|
448
|
536
|
534
|
566
|
611
|
727
|
789
|
836
|
|
| Short-Term Debt |
1 432
|
0
|
820
|
1 117
|
787
|
937
|
1 466
|
1 506
|
1 826
|
2 321
|
|
| Current Portion of Long-Term Debt |
591
|
1 688
|
348
|
422
|
495
|
532
|
707
|
649
|
1 108
|
1 020
|
|
| Other Current Liabilities |
697
|
890
|
1 253
|
1 372
|
1 450
|
1 231
|
1 697
|
1 964
|
2 513
|
2 454
|
|
| Total Current Liabilities |
5 698
|
5 160
|
5 517
|
6 409
|
6 688
|
6 292
|
7 806
|
8 754
|
10 314
|
10 608
|
|
| Long-Term Debt |
597
|
304
|
696
|
950
|
1 488
|
1 642
|
2 616
|
1 998
|
4 300
|
3 570
|
|
| Deferred Income Tax |
102
|
97
|
97
|
97
|
97
|
97
|
97
|
97
|
97
|
728
|
|
| Minority Interest |
2 352
|
2 349
|
2 471
|
2 765
|
3 074
|
3 350
|
3 870
|
4 726
|
5 688
|
6 566
|
|
| Other Liabilities |
346
|
575
|
548
|
336
|
317
|
317
|
408
|
597
|
722
|
453
|
|
| Total Liabilities |
9 095
N/A
|
8 485
-7%
|
9 329
+10%
|
10 557
+13%
|
11 664
+10%
|
11 699
+0%
|
14 797
+26%
|
16 172
+9%
|
21 121
+31%
|
21 925
+4%
|
|
| Equity | |||||||||||
| Common Stock |
1 208
|
1 208
|
1 208
|
1 208
|
1 208
|
1 208
|
1 208
|
1 208
|
1 208
|
1 208
|
|
| Retained Earnings |
12 630
|
13 230
|
14 364
|
15 834
|
17 532
|
18 755
|
20 705
|
23 090
|
26 076
|
28 839
|
|
| Additional Paid In Capital |
1 820
|
1 820
|
1 820
|
1 821
|
1 821
|
1 821
|
1 816
|
1 816
|
1 815
|
1 815
|
|
| Unrealized Security Profit/Loss |
42
|
0
|
4
|
167
|
44
|
88
|
85
|
289
|
432
|
1 050
|
|
| Treasury Stock |
509
|
0
|
509
|
509
|
509
|
509
|
509
|
510
|
510
|
510
|
|
| Other Equity |
850
|
304
|
228
|
406
|
321
|
206
|
582
|
911
|
870
|
1 241
|
|
| Total Equity |
16 041
N/A
|
15 932
-1%
|
17 106
+7%
|
18 926
+11%
|
20 416
+8%
|
21 392
+5%
|
23 886
+12%
|
26 803
+12%
|
29 890
+12%
|
33 643
+13%
|
|
| Total Liabilities & Equity |
25 135
N/A
|
24 417
-3%
|
26 435
+8%
|
29 482
+12%
|
32 080
+9%
|
33 091
+3%
|
38 683
+17%
|
42 975
+11%
|
51 012
+19%
|
55 568
+9%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
10
|
10
|
10
|
10
|
10
|
10
|
10
|
10
|
10
|
10
|
|